Effects of Iranian Traditional Medicine Combined product on Melasma
Phase 2
- Conditions
- Melasma.Other melanin hyperpigmentation Lentigo
- Registration Number
- IRCT2015112025145N1
- Lead Sponsor
- Mashhad University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 31
Inclusion Criteria
Female volunteerswith a diagnosis of melasma older than18 years.
Exclusion criteria: Gestation or lactation period; infectious skin disease;ovarian or thyroid malfunctions; use of contraceptives or antiepileptics; recently use of corticosteroids; patients have used bleaching agents in the last four months; laser & IPL therapy in six months ago; adverse effects of drugs; mental disorders or disability
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method MASI (Melasma Area and Severity Index) score. Timepoint: Before the intervention, every four weeks during the intervention& after 4 weeks of the intervention. Method of measurement: MASI scale.
- Secondary Outcome Measures
Name Time Method Side effects. Timepoint: During the study. Method of measurement: Question.